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Abstract
Alterations in the corticostriatal system have been implicated in numerous substance use disorders, including
alcohol use disorder (AUD). Adaptations in this neural system are associated with enhanced drug-seeking
behaviors following exposure to cues predicting drug availability. Therefore, understanding how potential
treatments alter neural activity in this system could lead to more refined and effective approaches for AUD. Local
field potentials (LFPs) were acquired simultaneously in the prefrontal cortex (PFC) and nucleus accumbens (NA)
of both alcohol preferring (P) and Wistar rats engaged in a Pavlovian conditioning paradigm wherein a light cue
signaled the availability of ethanol (EtOH). On test days, the catechol-o-methyl-transferase (COMT) inhibitor
tolcapone was administered prior to conditioning. Stimulus-evoked voltage changes were observed following the
presentation of the EtOH cue in both strains and were most pronounced in the PFC of P rats. Phase analyses of
LFPs in the  band (5–11 Hz) revealed that PFC-NA synchrony was reduced in P rats relative to Wistars but was
robustly increased during drinking. Presentation of the cue resulted in a larger phase reset in the PFC of P rats
but not Wistars, an effect that was attenuated by tolcapone. Additionally, tolcapone reduced cued EtOH intake
in P rat but not Wistars. These results suggest a link between corticostriatal synchrony and genetic risk for
excessive drinking. Moreover, inhibition of COMT within these systems may result in reduced attribution of
salience to reward paired stimuli via modulation of stimulus-evoked changes to cortical oscillations in genetically
susceptible populations.
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Significance Statement
Alcoholism is highly heritable and genetic vulnerability is associated with increased likelihood of alcohol
use-related problems. Presentation of environmental stimuli paired with alcohol are capable of inducing
craving and relapse in alcohol-dependent individuals. The work described here using a rodent model of
cued ethanol (EtOH) availability suggests that altered corticostriatal activity may be associated with genetic
vulnerability to abuse alcohol. Additionally, our data suggest that inhibition of the catechol-o-methyl-
transferase (COMT) enzyme activity may reduce the influence that alcohol-conditioned stimuli (CSs) elicit on
behavior, resulting in a reduction of cued alcohol seeking in genetically susceptible individuals.
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Introduction
Environmental stimuli associated with drugs of abuse
acquire motivational properties (Robinson and Berridge,
1993) capable of inducing drug craving (Myrick et al.,
2004; Reid et al., 2006) and seeking (Katner et al., 1999;
See, 2002). Exposure to these stimuli has been consis-
tently shown to activate brain regions across the meso-
corticolimbic (MCL) system, including the prefrontal
cortex (PFC) and nucleus accumbens (NA; Grusser et al.,
2004; Myrick et al., 2004; Oberlin et al., 2016). The acti-
vation of these structures by drug-paired cues (Schacht
et al., 2013) is thought to reflect the neural processes
required to assign salience to these cues (Berridge and
Robinson, 1998; Di Chiara, 1999). Furthermore, altered
PFC signaling to the NA is critical for the transition to
compulsive drinking (Seif et al., 2013). The goal of the
current study was to determine the influence of alcohol-
associated cues on neural synchrony between the PFC
and NA.
Theta oscillations (5–11 Hz, in the rat) have been shown
to facilitate plasticity (Abbott, 1992; Huerta and Lisman,
1996; Chauvette et al., 2012), as well as cognitive func-
tions such as, stimulus evaluation (Bas¸ar and Güntekin,
2008) and reward processing (Kamarajan et al., 2008; van
Wingerden et al., 2010a). Perturbations in  activity are
also associated with alcohol use (De Bruin et al., 2004;
Kamarajan et al., 2004, 2012; Jones et al., 2006b), expo-
sure (Krause et al., 2002), and genetic vulnerability to
alcohol dependence (Kamarajan et al., 2006; Rangas-
wamy et al., 2007; Andrew and Fein, 2010). Additionally,
individuals with alcohol use disorder (AUD) show altera-
tions in the P300 response (Cohen et al., 2002), which is
evoked by exposure to salient environmental stimuli
(Jones et al., 2006a) and is hypothesized to be driven by
changes in delta and  oscillations (Jones et al., 2006a).
Changes in  synchrony between MCL structures may,
therefore, convey risk for excessive drinking and provide
a target to develop novel therapies for AUDs.
Alcohol preferring (P) rats are a validated preclinical
model of AUD (Murphy et al., 2002; Froehlich, 2010; Bell
et al., 2017). P rats are selectively bred for alcohol pref-
erence and display a robust alcohol seeking and drinking
phenotype compared with their progenitor strain, Wistar
rats (Murphy et al., 2002). Similar to individuals with a
positive family history (FH) for AUD, P rats exhibit lower
P300 amplitudes relative to non-P rats (Ehlers et al.,
1999). P rats also exhibit reduced neural phase locking
(Criado and Ehlers, 2010), which is similar to impairments
in phase locking observed in long-term abstinent alcohol-
ics (Andrew and Fein, 2010). Higher neural firing rates in
the PFC of P rats versus control rats during a cued-
alcohol task (Linsenbardt and Lapish, 2015) are also con-
sistent with increases in alcohol-paired stimuli-evoked
activity in the PFC of FH individuals and individuals
diagnosed with an AUD (George et al., 2001; Myrick et al.,
2004; Kareken et al., 2010; Cservenka and Nagel, 2012).
These observed changes in neural activity of the P rat may
be attributable to observed alterations in regulatory sys-
tems, such as reduced expression of the glutamate
metabotropic receptor 2 (Zhou et al., 2013) and dopamine
(DA) levels in PFC (Engleman et al., 2006). Collectively,
these data support the use of the P rat as a translational
tool to investigate the relationship between neurophysio-
logical alterations and excessive drinking.
The catechol-o-methyl-transferase (COMT) enzyme
metabolizes catecholamine’s including DA in cortical re-
gions (Mazei et al., 2002; Morón et al., 2002). Using the
COMT inhibitor tolcapone, we have observed reductions
in cued ethanol (EtOH) consumption in P rats (McCane
et al., 2014) and reinforcer seeking (McCane et al., 2018).
Tolcapone enhances cued medial (m)PFC DA efflux (Lap-
ish et al., 2009) and therefore may remediate mPFC DA
deficits in P rats (Engleman et al., 2006). The current
experiments measured changes in neural activity in the
mPFC and NA during cued alcohol seeking. We hypoth-
esized that differences in  oscillations between P and
Wistar rats would underlie differences in alcohol seeking
behaviors and that tolcapone administration would nor-
malize aberrant neural activity in the P rat.
Materials and Methods
Behavior
A total of 63 datasets were analyzed from 16 animals: P
(N  10, 37 datasets; Indiana University) and Wistar (N 
6, 26 datasets; Harlan) rats. All animals arrived from both
respective outside vendors within the same week to en-
sure habituation and rearing conditions were identical
for both strains. Animals were single housed, weighed
250–300 g at the start of experiment, maintained on a
reverse light dark cycle and supplied with food and water
ad libitum. All animals initially received four weeks of
intermittent two bottle access for 20% EtOH to pre-
expose animals to EtOH (McCane et al., 2014; Linsen-
bardt and Lapish, 2015). Immediately following this
induction phase, animals began training in the two-way
cued access protocol (2CAP) as described previously
(McCane et al., 2014). Briefly, behavior was conducted in
a two-compartment operant chamber equipped with two
stimulus lights, and two retractable sippers, one on each
side of the chamber. Illumination of a stimulus light (con-
ditioned stimulus; CS) for 2 s was followed by a 1-s
interstimulus interval and then 10-s access to 10% EtOH
(unconditioned stimulus: US). Each session consisted of
40 CS/US pairings or trials, randomized between sides.
All animals had a minimum of three weeks conditioning
before electrophysiological recordings.
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Pharmacology
To assess the influence of COMT inhibition on cortico-
striatal network dynamics, animals were treated with
tolcapone (30 mg/kg) or vehicle (counterbalanced) as de-
scribed previously (McCane et al., 2014, 2018).
Electrophysiology
Following conditioning, animals were anesthetized with
isoflurane and implanted with custom-made electrophys-
iology probes. Probes were assembled using four 50-m
stainless-steel wires (California Fine Wires) fed through
silica tubing and then secured to custom-made head caps
via epoxy. Wires were externally referenced to a stainless-
steel skull screw over the cerebellum. Probes were im-
planted over the mPFC (AP: 3.0, ML: 0.5, DV: -3.2) and NA
(AP: 1.6, ML: 1.5, DV: -6.7; Fig. 1). Local field potentials
(LFPs) were acquired with a 96 channel Neuralynx Chee-
tah recording system. LFPs were sampled at 32,556 Hz,
amplified 2000 times, initially filtered between 0.01 and
1000 Hz, and then down sampled to 1017 Hz for analyses.
Each session was recorded with video tracking software
(Any-Maze) which was synchronized with the electrophys-
iological recoding system with submillisecond precision.
This allowed the location of the animals to be recorded as
x-, y-coordinates in separate voltage traces. These volt-
age traces were then used to compute the velocity of the
animal’s movement (Fig. 2). Lastly, video recordings were
manually scored to identify “drinking” versus “non-
drinking” trials, that is, the animals were clearly vigilant
and capable of observing the CS and then either con-
sumed or did not consume the EtOH presented
Power frequency analyses
Power spectral densities from the mPFC and NA were
computed via multi-taper spectral decomposition from
voltage traces extracted 10 s before, and 32 s after the
CS. A 95% confidence interval was derived via normfit.m
to test for significant differences between signals (Fig.
3A).
Spectral coherence analyses
Wavelet coherence was computed using the wcoher.m
function in MATLAB using Morelet wavelets smoothed
over 20 ms. Wavelet coherence spectra were calculated
on 30 s of the LFP signal extracted around the CS-fluid
sequence (Fig. 3). For each animal, spectra were calcu-
lated for each trial, smoothed via Gaussian kernel over 0.5
s in each frequency, and then averaged over all animals
for visualization and analysis.
Phase analyses
The phase locking analyses methods have been de-
scribed previously in detail (Park et al., 2010a; Ahn et al.,
2014). Briefly, signals were Kaiser windowed and digitally
filtered using a FIR filter in the  frequency band (5–11 Hz)
at the sampling rate of 1017 Hz. Zero phase filtering was
used to avoid phase distortions. Phase was extracted via
Hilbert transform resulting in two signals; 1t and 2t
(Pikovsky et al., 2001; Hurtado et al., 2004). To clarify, let
xt be the filtered signal at the given frequency band.
Then the complex analytic extension of xt is given by Eqn. 1
t  xt  i x t (1)
where xt is given by theHilbert transformof the signal (Eqn. 2)
xt  Hx  1

p.v.
	


 x
t 	 
d. (2)
Then the analytic signal is projected on the unit circle
(Eqn. 3)
zt 
t
t
 eit (3)
where t is the modulus of t. The phase t was
then extracted through the argument (angle) of zt.
Phase locking analyses
The following widely used measure of the strength of phase
locking between these two signals was calculated: (Eqn. 4)
   1
Nj1N eitj (4)
where 1t and 2t are two phases from the filtered
signals, the phase difference tj  1tj 	 2tj, tj are
the times of data points, and N is the number of all data
points during the given time interval. The values of this
phase locking index vary from 0 (no phase locking) to 1
(perfect phase locking). This kind of phase synchrony
index has been shown to be appropriate to study neural
oscillatory synchronization of widely varying strength
(Lachaux et al., 1999; Pikovsky et al., 2001; Hurtado et al.,
2004). To explore the changes of synchronized dynamics
for each of the three events over the trials, we computed
the phase synchrony index  for three epochs (before CS,
during US, after US) at each trial. A total of 33-s windows
was used. CS on occurred at 10 s, US on started 3 s after
CS on and lasted for 10 s, and US off started 10 s after the
end of US on.
Phase delay analyses
To investigate the impact of CS presentation on the
phase of the signals, we analyzed the phase delay. Phase
delay was calculated by first computing the averaged time
difference between peaks of LFP phases for 1 s before CS
on for each brain region (mPFC, NA). Then, the time
difference between the first peak right after the CS and
the last peak right before the CS was computed. Phase
delay was derived by computing the difference between
the first value and second value. Positive values indicate
that the CS causes a delay of peak while negative values
suggest that the CS causes the advance of the peak.
Intertrial phase coherence (ITPC)
To measure the CS-evoked precision of phases across
trials in the  band, ITPC was calculated. Drinking trials
were analyzed for 200 ms before, and 1 s after the CS.
ITPC was calculated per Delorme and Makeig, 2004:
(Eqn. 5)
ITPC  1
n
k1
n Fkf, t
Fkf, t
(5)
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After calculating ITPC for each trial, averages across
trials were taken in the  band (5–11 Hz) for each dataset.
Statistics were performed on the dataset-averaged time
series.
Statistical analyses
All analyses were performed in MATLAB (MathWorks)
and R (https://www.r-project.org/). Unless specified oth-
erwise, all comparisons were first subjected to ANOVA
testing or mixed-design ANOVA (a mixture of between
subject factor and within subject factors) followed by post
hoc tests for all multiple comparison procedures.
Results
Strain differences are observed in drinking and
locomotor behavior
Consistent with our previous findings (McCane et al.,
2014), behavioral differences were observed between
strains during 2CAP recording sessions. P rats consumed
more EtOH than Wistars (independent samples t test,
t(36)  4.56, p  5.70  10
5; Fig. 1A). However, P rats
and Wistars did not differ in the percentage of drinking
trials relative to non-drinking trials (independent samples
t test, t(36)  9.71  10
1, p  0.05; Fig. 1B). Additionally,
strain differences in locomotor activity were observed.
Movement velocity differed between P rats and Wistars,
on both drinking (main effect of strain: F(1,12073)  15.5, p
 8.21 105) and non-drinking trials (main effect of strain:
F(1,13748)  1972, p  9.21  10
6), trial  strain interaction
(F(1,15792)  2.90  10
1, p  7.46  108; Fig. 1C).
Theta synchrony between mPFC-NA increases when
P rats drink
On trials that animals drank, a robust change in
voltage of the mPFC and NA was observed following
the presentation of the CS in both strains of animals
(Fig. 2). The change in voltage response was charac-
terized most prominently by a fast negative going peak
that occurred 150 ms after the presentation of the CS
(Fig. 2A). Additionally, a slower positive going peak was
observed between 4 and 5 s following the CS that
roughly corresponded to the EtOH becoming available.
These peaks were observed in both strains of animals
and in both the mPFC and NA recordings (Fig. 2).
However, these peaks were not as prominent during
non-drinking trials (data not shown). P rats exhibited an
enhanced response in the initial, negative going peak
relative to Wistars in both the mPFC (strain  time
interaction F(300,162239) 1.39, p  1.05  10
5; Fig. 2A)
and the NA (main effect of strain F(1,162239)  2.78 
102, p  1.00  1016; main effect of time F(300,162239) 
3.15, p  1.00  1016; Fig. 2B).
Time-frequency and synchrony analyses were also per-
formed on the voltage responses. Peaks in  band were
observed in the PFC and NA power spectra (Fig. 3A).
Wavelet coherence was used to initially assess synchrony
A1 A2
B1 B2
Figure 1. Voltage traces (1) and electrode placements (2) in the mPFC (A) and NA (B) during drinking trials. P rats (red) exhibit an
augmented mPFC response to the CS (A1, inset) compared to Wistar rats (blue). All values are mean 	 SEM. Bar depicts time when
strains are different, p  0.05.
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between the mPFC and NA (Fig. 3B,C), as it is sensitive to
both phase and amplitude fluctuations and optimal for
nonstationary signals (Lachaux et al., 2002). Increases in 
synchrony were observed between the mPFC and NA on
drinking trials in both strains (Wistar, trial  time interac-
tion, F(4,170)  6.75, p  4.6  10
6; P rat, trial  time
interaction, F(4,190)  6.82, p  4.1  10
6). The increase
in mPFC-NA synchrony was more robust in P rats (Fig.
3D).
Phase synchrony during the US but not before the CS
was observed (Fig. 4A–C). To directly assess phase syn-
chrony between the mPFC and the NA, the synchrony
index () was computed (Fig. 4D,E) for three behavioral
epochs of the 2CAP (before the CS, during the US, and
after the US) across the first 15 drinking and non-drinking
trials. To investigate the trial by trial changes in , a
mixed-design ANOVA [between subject factors strain
(Wistar, P) and within subject factors epoch (before CS,
during US, or after US), drinking status (drinking, non-
drinking trials), and trial number (1–15)]. There was a
significant main effect of drinking status (F(1,21)  1.39 
101, p  1.26  103), indicating that, overall, synchrony
differed for trials in which animals chose to drink versus
trials where animals abstained.
Synchrony was next analyzed for drinking and non-
drinking trials separately. A mixed-design ANOVA on
non-drinking trials revealed a significant main effect of
trial number (F(14,378)  2.42, p  2.97  10
3; Fig. 4D).
However, no effects of strain (F(1,27)  4.00, p  0.05) or
epoch (F(2,54)  2.63  10
1, p  0.05) were observed.
Additionally, no two-way or three-way interactions were
detected (ps  0.05). Collectively, these data indicate
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Figure 2. P rats consumemore EtOH across sessions relative to Wistars (A) but do not differ in percentage of drinking trials (B). Overall
movement velocities differ by strain for both drinking and non-drinking trials but both strains show a reduction in locomotor activity
during drinking (C2) but not non-drinking trials (C1). All values are mean 	 SEM; #p  0.05, independent samples t test; p  0.05,
main effect of strain.
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A2A1
C1B1
C2B2
D2D1
Figure 3. Theta oscillation are present in the 2CAP and are associated with drinking behaviors. Power spectral densities (A) in the mPFC
(1) and NA (2) show a prominent peak in the  frequency. Mean traces of mPFC-NA spectral coherence during non-drinking (1) and drinking
(2) trials in Wistars (B) and P rats (C). Theta band wavelet coherence between the mPFC and NA for non-drinking (cyan, pink) and drinking
(blue, red) trials in Wistars (D1) and P rats (D2); p  0.05 Bonferroni post hoc, drinking versus non-drinking.
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A2
D1 D2
E1 E2
CB
A1
Figure 4. Physiologic differences are observed in the phase domain. Phase synchrony between the mPFC (black) and NA (gray) before
drinking (A1) and during drinking (A2) indicate oscillations are more in phase during drinking, relative to before drinking. The difference
in phase during (purple) and before (orange) drinking (B). Histogram of phase difference during drinking trials, notice more pronounced
peak at zero indicating more synchronized phases (C). Theta band synchrony index () for Wistar (D1, E1) and P rats (D2, E2) before
the CS (orange), during the US (purple), and after the US (green) over 15 non-drinking (D) and drinking trials (E). Values are mean 	
SEM.
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that, on non-drinking trials, the observed synchrony is
influenced by trial number but not strain or epoch.
On drinking trials, significant main effects of strain
(F(1,29)  4.64, p  3.97  10
2), epoch (F(2,58)  1.50 
102, p  5.45  106), and trial number (F(14,406)  4.61,
p 8.72 108) were observed. Post hoc tests indicated
that phase synchrony for Wistars was significantly
higher overall compared to P rats (Tukey’s HSD, p 
4.40  102; Fig. 4E). Also, synchrony during the US
was significantly higher compared to a baseline period
that occurred immediately before the CS (Tukey’s HSD,
p  6.16  104) and immediately after the sipper was
removed from the chamber (Tukey’s HSD, p  4.01 
103). Additionally there were significant strain  epoch
(F(2,58)  1.10  10
1, p  8.69  105), and strain  trial
(F(14,406)  2.89, p  3.52  10
4) interactions, indicat-
ing the pattern of phase synchrony across trials and
epochs was different across rat strain. Therefore, drink-
ing trials were analyzed separately for Wistar and P rats
to determine differences in synchrony across each ep-
och and trial.
In Wistars, synchrony decreased across drinking trials
(main effect of trial number, F(14,182)  5.18, p  3.48 
108), but neither a main effect of epoch (F(2,26)  1.76 
101, p 0.05) nor an epoch trial interaction (F(28,364)
1.33, p  0.05) were observed (Fig. 4E1). These data
indicate that, in Wistars, while synchrony changes across
drinking trials, it is not influenced by epoch.
In P rats, synchrony did not change across drinking
trials (main effect of trial number, F(14,224)  1.40, p 
0.05). However, synchrony differed by epoch (main effect
of epoch, F(2,32)  2.62  10
1, p  1.82  107; Fig. 4E2).
Post hoc tests indicated that synchrony during drinking
(US) was significantly higher than synchrony before CS
presentation (Tukey’s HSD, p  1.43  104) and after
drinking (Tukey’s HSD, p  3.27  104). There was no
difference in synchrony before CS on and after drinking
(Tukey’s HSD, p  0.05). In summary, consistent with
wavelet coherence analyses, increases in  band syn-
chrony were observed when alcohol was available during
drinking trials (Fig. 4). The time scale of increases in
drinking suggest that increases in the  synchrony corre-
spond to when P rats are consuming alcohol since the
increase was consistently observed over trials during the
drinking epoch.
Presentation of the CS affects oscillatory dynamics
To determine how the presentation of the CS influenced
oscillatory dynamics, changes in  phase over time in the
mPFC and NA were assessed (Fig. 5). To determine how
the CS affects the phase of the signals, we assessed the
phase-response curve. This measures the time difference
between peaks of an oscillation, thus providing an index
of phase precision within a trial and a way to detect phase
resets. Phase-response curves were computed for the 
filtered LFP signal around the CS for each brain region
(mPFC and NA separately). In both Wistars and P rats, the
mean phase-response curve values for both brain regions
were positive, indicating that presentation of the CS is
associated with increases in the latency to the next peak
of the  phase following the CS thus indicating a phase
reset (Fig. 5A,B). To further investigate the CS-evoked
phase reset, a mixed-design ANOVA (between subject
factor strain and within subject factors brain region and
trial numbers) was performed. During drinking trials, there
was a significant main effect of strain (F(1,29)  4.37, p 
4.54  102) but not brain region (F(1,29)  3.48, p  0.05)
or trial number (F(14,406)  5.97  10
1, p  0.05). Both
two-way and three-way interactions were not significant
(ps 0.05). Next, the difference of the phase delays was
assessed for both strains in each brain region sepa-
rately. In the mPFC, the phase delay of P rats was
significantly longer compared to Wistars (Tukey’s HSD,
p  3.52  102; Fig. 5B). However, there was no
difference between Wistar and P rats in the NA (Tukey’s
HSD, p  0.05). During non-drinking trials, a mixed-
design ANOVA was employed to investigate the change
in the phase of the signals due to CS presentation.
There was no main effect of strain (F(1,28)  1.36 
101, p  0.05), brain region (F(1,28)  1.51  10
1, p 
0.05) or trial number (F(14,392)  1.39, p  0.05; Fig.
5B1). Both two-way and three-way interactions were
not significant (ps  0.05). Collectively these analyses
indicate that the phase resets are most robust in P rats
in the mPFC on drinking trials.
Stimulus evoked correlations in neural activity have
been suggested to play a role in encoding of environmen-
tal stimuli and neural plasticity (Mazzoni et al., 2008). To
determine if the phase resets detected in the previous
analyses lead to stimulus-evoked synchrony in the
phases of mPFC LFP’s, ITPC was assessed across drink-
ing and non-drinking trials. Transient increases in ITPC
were observed in both Wistars (repeated-measures
ANOVA, main effect of time, F(23,391)  3.02, p  5.50 
106) and P rats (repeated-measures ANOVA, main effect
of time, F(23,437)  3.73, p  0.1  10
6). CS-evoked
changes in ITPC were assessed by comparing ITPC val-
ues 200 ms before stimulus onset to values 1 s after CS
presentation (Fig. 5D). Wistars exhibited increases in ITPC
50 ms following the CS, whereas P rats exhibited in-
creases for 200 ms following ITPC (Fig. 5D). Collectively
these data indicate that CS-evoked increases in ITPC are
observed in both strains of animals.
Tolcapone reduces EtOH intake and number of
drinking trials in P rats
Following treatment with either saline or tolcapone, the
amount of EtOH consumed and the number of drinking
trials were assessed. For intake, there was a significant
main effect of treatment (F(1,22)  1.47  10
1, p  9.01 
104) but no effect of strain (F(1,22)  7.23  10
1, p 
0.05). There was also a significant strain  treatment
interaction (F(1,22)  4.39, p  4.79  10
2). Post hoc test
indicated that tolcapone decreased intake of EtOH
(Tukey’s HSD, p  9.01  104). In particular, tolcapone
decreased intake in P rats (Tukey’s HSD, p  1.35 
103) but not Wistars (Tukey’s HSD, p  0.05; Fig. 6A).
For the percentage of drinking trials, a significant main
effect of treatment (F(1,18)  6.19, p  2.28  10
2) was
observed, but no main effect of strain (F(1,18)  1.14, p 
New Research 8 of 15
September/October 2018, 5(5) e0326-18.2018 eNeuro.org
AB1 B2
C1 C2
D1 D2
Figure 5. A pronounced phase reset is observed in the mPFC following presentation of the CS (A). MPFC and NA phase delay duration
during non-drinking (B1) and drinking (B2) trials in Wistar (blue) and P rats (red). During non-drinking trials, there was no effect of the
CS on the phase of the oscillation (B1). During drinking trials, P rats exhibit a greater CS-evoked phase delay in the mPFC, relative
to Wistars (B2). There was no effect of the CS on phase delay in the NA. ITPC spectrograms (C) and phase coherence (D) for Wistar
(1) and P rats (2). Both strains exhibit increases in ITPC following the CS; #p  0.05, main effect of strain; p  0.05, Bonferroni post
hoc, time different from baseline (200 ms before CS).
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0.05) or strain  treatment interaction (F(1,18)  8.39 
101, p 0.05) were observed. Post hoc testing indicated
that treatment with tolcapone resulted in fewer drinking
trials compared to treatment with saline (Tukey’s HSD,
p  2.28  102; Fig. 6B).
Tolcapone attenuates mPFC-NA synchrony
In the following analyses, data are collapsed across trial
number due to the few drinking trials observed following
tolcapone treatment in P rats. There was no effect of tolca-
pone on CS-evoked changes in voltage (Fig. 2) in either
A B
C1
C2
Figure 6. The behavioral and physiologic effects of tolcapone. Tolcapone decreases EtOH intake (A) in P rats but not Wistars and
number of drinking trials in both strains (B). Tolcapone reduces mPFC-NA synchrony in Wistars (C); p  0.05, Bonferroni post hoc,
main effect of treatment in P rats; #p  0.05 main effect of treatment.
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strain or brain region (ps  0.05; data not shown). To inves-
tigate the effects of tolcapone on mPFC-NA synchrony (),
we performed a four-way ANOVA with treatment (saline or
tolcapone), strain, epoch, and drinking status (drinking or
non-drinking trials) as factors. There were significant main
effects of treatment (F(1,1635) 3.16 10
1, p 2.27 108),
strain (F(1,1635) 1.72 10
2, p 1.0 1016), and drinking
status (F(1,1635)  5.24, p  2.21  10
2), but not epoch
(F(2,1635)  1.47, p  0.05). There was also a significant
treatment  strain interaction (F(1,1635)  2.83  10
1, p 
1.17  107), while all other two-way, three-way, or four-
way interactions were not significant (ps  0.05). Post hoc
tests indicated that administration of tolcapone resulted in
reduced mPFC-NA synchrony (Tukey’s HSD, p  1.95 
108; Fig. 6C), an effect driven by a tolcapone mediated
reduction in Wistars (Tukey’s HSD, p  1.06  1010) but
not P rats (Tukey’s HSD, p  0.05). Consistent with non-
treatment sessions, overall mPFC-NA synchrony in Wistars
was higher compared to P rats (Tukey’s HSD, p  1.67 
1010). Moreover, mPFC-NA synchrony during drinking trials
was significantly higher than during non-drinking trials
(Tukey’s HSD, p  2.20  102).
Tolcapone reduces CS-evoked phase delays in P
rats
Phase-response curves were computed to assess CS-
induced phase resets following treatment and were
collapsed across trials. A four-way ANOVA (factors: treat-
ment, strain, drinking status, brain region) was performed.
There was a significant main effect of strain (F(1,1168) 
7.31, p 6.96 103). Post hoc testing indicated that the
phase delays of P rats were significantly shorter com-
pared to Wistars (Tukey’s HSD, p 6.86 103; Fig. 7A).
There were no other main effects of treatment (F(1,1168) 
3.07 101, p 0.05), drinking (F(1,1168) 1.37, p 0.05)
or brain region (F(1,1168)  2.30  10
1, p  0.05). How-
ever, there was a significant treatment strain interaction
(F(1,1168)  4.24, p  3.97  10
2). Post hoc testing
indicated that tolcapone reduced the phase delay in the
mPFC of Prats during drinking trials (Tukey’s HSD, p 
7.48  103; Fig. 7A2); an effect not observed during
non-drinking trials, in Wistars or in the NA (ps  0.05).
Similar to non-treatment sessions, a main effect of strain
was observed (F(1,464) 1.08 10
1, p 1.08 103) with
post hoc test indicating a shorter phase delay in P rats,
relative to Wistars (Tukey’s HSD, p  1.00  103).
To further determine how changes CS-evoked syn-
chrony were influenced by treatment, ITPC was assessed
following saline and tolcapone injections on drinking
trials. In Wistars, no main effect of time was observed
following saline administration (repeated-measures ANOVA,
F(23,69)  1.09, p  0.37), whereas a main effect of time
was observed following tolcapone administration (repea-
ted-measures ANOVA, F(23,92)  3.00, p  1.04  10
4;
B2
A2A1
B1
Figure 7. The effects of tolcapone on the phase delay in Wistar (A1; blue) and P rats (A2; red) in the mPFC. Mean phase coherence
(B) in Wistar (left) and P rats (right) under saline or tolcapone treatment. Tolcapone reduces the phase delay in P rats but not Wistars
(A2). Tolcapone results in increased phase coherence following the CS in Wistars (B1) but not P rats (B2); #p  0.05 Tukey’s HSD
post hoc; p  0.05, time different from baseline.
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Fig. 7B). In P rats a main effect of time was observed
following saline (repeated-measures ANOVA, F(23,115) 
2.95, p  7.41  105), but not tolcapone (repeated-
measures ANOVA, F(23,161)  1.30, p  0.178).
Discussion
These experiments investigated the neural mechanisms
by which drug paired stimuli elicit reward seeking in a
rodent model of addiction vulnerability. Relative to
Wistars, P rats exhibited an increase in mPFC-NA syn-
chrony when drinking and a greater CS-induced phase
delay in mPFC. Following tolcapone administration, a
reduction in EtOH intake in P but not Wistar rats was
observed. While no effect of tolcapone on synchrony in P
rats was observed, a tolcapone-mediated suppression of
the mPFC phase delay was observed in P rats but not
Wistars during drinking trials only. These data suggest a
novel neural mechanism whereby tolcapone suppresses
drinking in genetically susceptible populations. These
data also further elucidate the modulatory role of cat-
echolamines in the corticostriatal system on alcohol seek-
ing behaviors.
Corticostriatal synchrony is associated with drug-
seeking phenotypes
Theta oscillations in the mPFC are hypothesized to play
a critical role in encoding reward value. MPFC  phase
locking was shown to be present during both reinforced
and non-reinforced licks in a high-value context while
phase locking was notably weaker during both reinforced
and non-reinforced licks in a low-value context, suggest-
ing that the strength of mPFC  activity corresponds to
reward value (Amarante et al., 2017). Stronger frontal
cortex  phase locking was observed in anticipation of
sucrose compared to quinine (van Wingerden et al.,
2010b), further suggesting  oscillations encode subjec-
tive value of a reward.
In the present experiment, P rats exhibited lower
mPFC-NA  synchrony than Wistars overall (Fig. 4D,E).
Low synchrony may reflect impairments in corticostriatal
connectivity and contribute to the excessive drinking phe-
notype of the P rat. Reduced corticostriatal synchrony is
associated with impaired executive function in AUD
(Courtney et al., 2013). Moreover, deficits in corticostriatal
connectivity are hypothesized to result in a reduction in
inhibitory control of the mPFC over the striatum, resulting
in poor control over behavioral responding and, possibly,
a precursor to compulsive behaviors (Forbes et al., 2014).
Poor frontal-striatal synchrony is also associated with
alcohol craving (Park et al., 2010b) and dependence se-
verity (Courtney et al., 2013). While the current study is not
able to differentiate whether strain differences in cortico-
striatal synchrony are a consequence of alcohol expo-
sure, genetic background, or an interaction of the two,
human imaging studies suggest that impaired connectiv-
ity may be associated with genetic vulnerability to addic-
tion disorders. Alcohol naïve youth with a family history of
alcohol showed reduced corticostriatal synchrony relative
to youths with no family history (Cservenka et al., 2014).
FH individuals also exhibit reduced cortical activation
during behavioral inhibition (Schweinsburg et al., 2004)
and greater frontal response to alcohol paired stimuli
(Kareken et al., 2010), which further suggests that altered
activity in the PFC and striatum may be associated with
genetic vulnerability for addiction. Importantly, these data
support the hypothesis that impaired frontal-striatal con-
nectivity may be an endophenotype for alcohol addiction
and lend further credibility to the use of the P rat as a
translational model of AUD symptoms.
Alcohol is hypothesized to disrupt the structure of os-
cillations by making them asynchronous (Ehlers et al.,
1998; Rangaswamy and Porjesz, 2014). Alcohol exposure
decreases the prevalence of  oscillations (Givens, 1995)
and  power (Ehlers et al., 1992). Because P rats typically
consume more EtOH than Wistars, reduced overall
mPFC-NA synchrony may be linked to differences in
EtOH exposure. In line with this view, EtOH administration
reduced phase locking to an auditory stimulus in both rats
and humans and these EtOH-induced changes were cor-
related with blood EtOH concentrations and subjective
measures of EtOH intoxication (Ehlers et al., 2012). How-
ever, while no differences in mPFC-NA synchrony were
observed over trials in P rats, a decrease was observed in
Wistars. Similarly, our group has shown that the effects of
alcohol on neural firing in the mPFC are influenced by rat
strain (Linsenbardt and Lapish, 2015). These findings add
complexity to the perhaps too simplified view that the
pharmacological effects of EtOH are disruptive to syn-
chrony. Rather, these data indicate that effects of EtOH
on mPFC-NA synchrony can be influenced by genetic
background.
A wealth of literature supports the hypothesis that
PFC-NA connections are important for reward seeking,
especially in the presence of CSs (Stefanik et al., 2013;
McGlinchey et al., 2016). In the current study, tolcapone
administration led to modest reductions in mPFC-NA syn-
chrony in Wistars but not P rats. In contrast, tolcapone
reduced EtOH intake in P rats but not Wistars. These data
suggest a dissociation between mPFC-NA synchrony and
EtOH consumption and that increases in catecholamine
efflux evoked by tolcapone do not prevent synchrony
between the mPFC and NA. Moreover, these data further
suggest that the critical site of action of tolcapone is in
mPFC.
Cue-evoked alterations in  phase is associated with
alcohol seeking in P rats
A robust  phase reset was observed in mPFC following
cue presentation (Fig. 5B2). Phase resets have been
shown to provide a timing mechanism that ensures opti-
mal processing of inputs coming into a brain region by
temporally aligning an oscillation to enhance information
processing (Lakatos et al., 2007; Rajkai et al., 2008; Mel-
loni et al., 2009). They are often observed in response to
exposure to a salient environmental stimulus. Further-
more, phase resets are associated with expression of
conditioned responses (Courtin et al., 2014) and emerge
as the relationship between a CS and response is learned
(Taub et al., 2018). Presentation of a CS also results in an
increase in amplitude and phase reset of  oscillations
(Courtin et al., 2014). Therefore, it is not surprising that a
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 phase reset was observed following cue presentation in
the current study and the phase reset is not likely specific
to processing an alcohol-associated cue but, more gen-
erally, reflects an environmentally salient stimulus. How-
ever, the fact that the phase reset was more pronounced
in P rats on drinking trials (Fig. 5B2) indicates that it
contributes in some way to the motivating effects of the
cue to elicit drinking and is possibly associated with an
enhanced risk for excessive drinking.
Tolcapone-mediated reduction of CS-evoked
responses is associated with reduced EtOH
consumption
Alcohol associated cues elicit increases in the frontal
BOLD response (Oberlin et al., 2016) and the extent of
activation of these regions is correlated with alcohol crav-
ing (Myrick et al., 2004). Stimuli paired with reward come
to possess motivational properties (Robinson and Ber-
ridge, 2001) and are themselves capable of inducing drug
wanting or craving in drug-dependent individuals (Reid
et al., 2006; Vollstädt-Klein et al., 2012). In the experi-
ments presented here, tolcapone administration blunted
the CS-evoked phase reset in P rats, which may have led
to a reduction in the motivational salience of the CS. In
human subjects, tolcapone reduced reaction time and the
ability of subjects to make the correct saccade following
a visual cue (Cameron et al., 2018), suggesting that COMT
inhibition may dampen salience attribution and subse-
quent attention to stimuli. We have previously reported
null effects of tolcapone on free-choice drinking but re-
duced cued EtOH consumption, supporting the hypothe-
sis that tolcapone-mediated changes in EtOH intake
observed here are cue dependent (McCane et al., 2014).
Therefore, we hypothesize that tolcapone-mediated dis-
ruption of the phase reset may contribute to blunted
incentive motivational properties of the cue.
Strain differences in tolcapone’s ability to reduce the
phase reset may be associated with differences in basal
DA tone and subsequent differences in cue-evoked DA
transmission. Alcohol-paired cues elicit increases in DA
concentrations in both clinical (Volkow et al., 2006; Ober-
lin et al., 2013) and preclinical subjects with a history of
drinking (Melendez et al., 2002). Repeated presentation of
reward-paired stimuli can strengthen both cortical stimu-
lus representation and neural responses to these stimuli,
an effect enhanced when paired with DA efflux (Bao et al.,
2001; Frankó et al., 2010). Tolcapone has no effect on
basal DA tone but instead enhances evoked DA release
(Tunbridge et al., 2004; Lapish et al., 2009). In P rats,
tolcapone may diminish the influence that stimuli have
over behavior by preventing the metabolism of cortical DA
and increasing tone on DA auto receptors. The effect of
increased DA would be blunted in Wistars who already
exhibit greater levels of extracellular DA coupled with
increased expression of COMT in mPFC and therefore a
greater capacity to buffer changes in DA efflux (Engleman
et al., 2006; McCane et al., 2018).
The results obtained here highlight the heterogeneity of
factors which may contribute to excessive drinking phe-
notypes. Whereas alterations in corticostriatal synchrony
may be associated with excessive drinking, catechol-
amine activity in the PFC appears to more strongly influ-
ence attribution of motivational salience to drug paired
stimuli in addiction vulnerable organisms. These results
highlight the role that catecholamines play on shaping
how motivating stimuli are processed by PFC. Further-
more, these results suggest that targeting the catechol-
amine system in PFC may provide an effective way to
blunt the incentive motivational properties of drug-
associated stimuli. In this way, novel treatments that tar-
get this system might be effective in preventing craving
and relapse.
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